title: Lepirudin: is the approved dosing schedule too high?
authors.forename: M
authors.initials: M
authors.lastname: Hacquard
authors.forename: E
authors.initials: E
authors.lastname: de Maistre
authors.forename: T
authors.initials: T
authors.lastname: Lecompte
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006629:Hirudins / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D013923:Thromboembolism / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; C083544:lepirudin